Skip to content

SCHEDULE 13D/AAccepted Feb 23, 4:37 PM ET

Lantern Pharma Inc. SCHEDULE 13D/A

Bios Equity Partners, LP

sec.gov(opens the filing on sec.gov)

Accepted (ET)

4:37 PM

Feb 23, 2026

Filed

Feb 23, 2026

Documents

1

Size

37.6 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.